Elutia Inc
NASDAQ:ELUT

Watchlist Manager
Elutia Inc Logo
Elutia Inc
NASDAQ:ELUT
Watchlist
Price: 0.6886 USD -4.76% Market Closed
Market Cap: 29.4m USD

Wall Street
Price Targets

ELUT Price Targets Summary
Elutia Inc

Wall Street analysts forecast ELUT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELUT is 3.57 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

Lowest
Price Target
2.02 USD
193% Upside
Average
Price Target
3.57 USD
418% Upside
Highest
Price Target
5.25 USD
662% Upside
Elutia Inc Competitors:
Price Targets
IMMU
Mendus AB (publ)
204% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
8% Upside
RXRX
Recursion Pharmaceuticals Inc
48% Upside
GLTO
Galecto Inc
68% Upside
EDT
Spectral Medical Inc
120% Upside
XOMA
XOMA Corp
146% Upside
NIOX
Niox Group PLC
23% Upside
688363
Bloomage Biotechnology Corp Ltd
1% Upside

Revenue
Forecast

Revenue Estimate
Elutia Inc

For the last 5 years the compound annual growth rate for Elutia Inc's revenue is -11%. The projected CAGR for the next 3 years is -7%.

-11%
Past Growth
-7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Elutia Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Elutia Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ELUT's stock price target?
Price Target
3.57 USD

According to Wall Street analysts, the average 1-year price target for ELUT is 3.57 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

What is Elutia Inc's Revenue forecast?
Projected CAGR
-7%

For the last 5 years the compound annual growth rate for Elutia Inc's revenue is -11%. The projected CAGR for the next 3 years is -7%.

Back to Top